These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 3003037)
21. GABA system: clinical research and treatment of tardive dyskinesia. Thaker GK; Hare TA; Tamminga CA Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061 [No Abstract] [Full Text] [Related]
22. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics]. Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J Encephale; 1982; 8(3):371-6. PubMed ID: 6137357 [TBL] [Abstract][Full Text] [Related]
23. Lithium in tardive dyskinesia. Simpson GM; Branchey MH; Lee JH; Voitashevsky A; Zoubok B Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):76-80. PubMed ID: 790411 [TBL] [Abstract][Full Text] [Related]
24. Lecithin administration in tardive dyskinesia: clinical and biomedical correlates. Jackson IV; Davis LG; Cohen RK; Nuttall EA Biol Psychiatry; 1981 Jan; 16(1):85-90. PubMed ID: 7225479 [No Abstract] [Full Text] [Related]
28. Treatment of chronic dyskinesia with CDP-choline. Arranz J; Ganoza C Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469 [TBL] [Abstract][Full Text] [Related]
29. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Gelenberg AJ; Doller-Wojcik JC; Growdon JH Am J Psychiatry; 1979 Jun; 136(6):772-6. PubMed ID: 375755 [TBL] [Abstract][Full Text] [Related]
30. Choline and lecithin for the treatment of tardive dyskinesia [proceedings]. Gelenberg AJ Psychopharmacol Bull; 1979 Apr; 15(2):74-5. PubMed ID: 432384 [No Abstract] [Full Text] [Related]
31. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810 [TBL] [Abstract][Full Text] [Related]
32. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia. Alpert M; Friedhoff AJ; Diamond F Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444 [No Abstract] [Full Text] [Related]
35. Pharmacological treatments of tardive dyskinesia in the 1980s. Jeste DV; Lohr JB; Clark K; Wyatt RJ J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):38S-48S. PubMed ID: 3065364 [TBL] [Abstract][Full Text] [Related]
36. The effect of sodium valproate on tardive dyskinesia--revisited. Fisk GG; York SM Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156 [TBL] [Abstract][Full Text] [Related]
37. Choline and lecithin administration to patients with tardive dyskinesia. Growdon JH; Gelenberg AJ Trans Am Neurol Assoc; 1978; 103():95-9. PubMed ID: 757093 [No Abstract] [Full Text] [Related]
38. Pilot study of cyproheptadine (Periactin) in tardive dyskinesia [proceedings]. Gardos G; Cole JO Psychopharmacol Bull; 1978 Apr; 14(2):18-20. PubMed ID: 349599 [No Abstract] [Full Text] [Related]
39. Cholinergic treatments for tardive dyskinesia. Alphs LD; Davis JM Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629 [No Abstract] [Full Text] [Related]
40. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]